1. Home
  2. CSBR vs DRIO Comparison

CSBR vs DRIO Comparison

Compare CSBR & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

N/A

Current Price

$4.90

Market Cap

68.8M

Sector

Health Care

ML Signal

N/A

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$5.45

Market Cap

56.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSBR
DRIO
Founded
1985
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.8M
56.8M
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
CSBR
DRIO
Price
$4.90
$5.45
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $13.60
AVG Volume (30 Days)
12.8K
★ 14.9K
Earning Date
09-10-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1559.02
EPS
N/A
★ 1.75
Revenue
$2,900,000.00
★ $7,394,000.00
Revenue This Year
$9.83
N/A
Revenue Next Year
$8.50
$38.77
P/E Ratio
★ N/A
$3.10
Revenue Growth
N/A
★ 43.02
52 Week Low
$4.59
$5.33
52 Week High
$8.31
$16.50

Technical Indicators

Market Signals
Indicator
CSBR
DRIO
Relative Strength Index (RSI) 47.28 34.83
Support Level $4.81 N/A
Resistance Level $6.29 $8.01
Average True Range (ATR) 0.16 0.44
MACD 0.00 -0.10
Stochastic Oscillator 45.65 10.96

Price Performance

Historical Comparison
CSBR
DRIO

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Share on Social Networks: